Clinical Trial Update: Ketotifen in Non-Alcoholic Fatty Liver Disease Patients [Phase 4]

View source ↗

Summary

Ketotifen was studied in patients with non-alcoholic fatty liver disease in a Phase 4 trial. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Ketotifen (Ketotifen)

Snippet

Sponsor: Tanta University | Conditions: Hepatic Disease | Phase 4 | Status: COMPLETED